开放存取 开放存取  受限制的访问 ##reader.subscriptionAccessGranted##  受限制的访问 订阅或者付费存取

卷 13, 编号 1 (2021)

封面

完整期次

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

Reviews

Myocardial infarction type 2 and myocardial injury: The current state of the problem

Oblavatskiy D., Boldueva S., Solovyeva M.

摘要

Today, the most difficult in terms of diagnosis and treatment today among various types of myocardial infarction (MI) is MI type 2 (MI-2). The lack of clinical guidelines for management of patients with this type of MI, as well as the literature data on prevalence, patient characteristics and prognosis contributes to the scientific relevance of the further research.

HERALD of North-Western State Medical University named after I.I. Mechnikov. 2021;13(1):5-13
pages 5-13 views

Therapeutic potential of the stromal vascular fraction in COVID-19

Pavlov V., Kazikhinurov A., Kazikhinurov R., Agaverdiyev M., Gareev I., Beylerli O., Mazorov B.

摘要

The new coronavirus infection (COVID-19) is already known to cause serious respiratory illnesses such as pneumonia and lung failure. COVID-19 has caused catastrophic damage to the public health, economic and social stability. As COVID-19 has resulted in enormous human toll and serious economic loss that poses a global threat, urgent understanding of the current situation and the development of strategies to mitigate the spread of the virus is required. Today, many studies are being carried out around the world to study the pathogenesis of COVID-19, where the development of a “cytokine storm” or pulmonary fibrosis is a serious complication that can lead to unfavorable outcomes. This leads to the fact that a deeper understanding of the nature of the virus will allow to develop new approaches in pathogenetic therapy. In this regard, the stromal vascular fraction has tremendous therapeutic potential in COVID-19. Stromal vascular fraction provides anti-inflammatory and immunomodulatory effects and promotes the restoration and regeneration of damaged tissues. The availability, the ability to obtain a significant volume of viable cells of the stromal vascular fraction population, such as adipose tissue stem / stromal cells, as well as their use by the intravenous route, has proven safe and effective in other forms of lung disease, including fibrotic diseases. In other words, the goal of this therapy for COVID-19 is to eliminate the inflammatory process, restore trophic and regenerate damaged tissues, and remodel fibrous and connective tissue. However, stromal vascular fraction is not currently approved for the prevention or treatment of COVID-19 cases. However, clinical trials are ongoing to ensure maximum understanding in terms of efficacy and safety. In this paper, we will discuss this new approach to the use of stromal vascular fraction therapy, which serves as a “ray of hope” in the fight against severe forms of COVID-19

HERALD of North-Western State Medical University named after I.I. Mechnikov. 2021;13(1):15-26
pages 15-26 views

Clinical, laboratory and instrumental evaluation of structural and functional changes of the liver in patients with heart failure

Kisliuk K., Bogdanov A., Shcherbak S., Apalko S.

摘要

Heart failure is detected in 2% of the population. The leading causes of heart failure are coronary heart disease, arterial hypertension, and valvular heart disease. The number of patients with chronic heart failure continues to increase despite the new methods of diagnosis and treatment. A special contribution is made by damage to target organs in the development of cardiovascular pathology. Impaired liver function or congestive liver is common in heart failure and increases the risk of death and requires further study. The mechanism of liver damage in chronic heart failure is complex and multicomponent. The sensitivity and specificity of standard clinical, laboratory and instrumental methods for the diagnosis of congestive liver are insufficient. With the increase, severity and duration of venous congestion, structural changes in the architectonics occur, leading to the formation of liver fibrosis. The development of cardiac liver fibrosis leads to a complication of the course of chronic heart failure and an increase in mortality.

Among the new diagnostic methods, the most important are serological markers of liver fibrosis, which have high diagnostic accuracy, as well as histological determination of fibrosis, as well as ultrasound examination of the liver in B-mode and determination of liver stiffness by elastography. Direct and indirect serological markers have a higher diagnostic value when using their combination in the composition of panels in the development of hepatopathy of different origins. An increase in the concentration of markers of fibrosis and liver stiffness during elastography correlates with the severity of heart failure and a long-term prognosis for mortality, including from extrahepatic diseases. Performing liver elastography in dynamics allows to monitor the course and treatment of heart failure. The optimal diagnostic method is a combination of direct and indirect markers of fibrosis, ultrasound diagnostics and elastography, in addition to clinical assessment of signs and direct assessment of hemodynamic parameters.

HERALD of North-Western State Medical University named after I.I. Mechnikov. 2021;13(1):27-37
pages 27-37 views

Original research

最可能的与靠谱系统性红斑狼疮患者皮肤活检中免疫学标志物的概述

Lila V., Mazurov V.

摘要

这项研究的目的是研究最可能的与靠谱系统性红斑狼疮患者的完整皮肤免疫反应谱。这项研究涉及94名患者,他们接受了标准的临床和实验室检查,并在三角肌区域进行了皮肤活检(狼疮带试验)。在靠谱系统性红斑狼疮的患者组(n=56),根据SLEDAI-2K,狼疮带试验在60.7%的病例中呈阳性,并与疾病活动相关(p=0.001)。同时,皮肤活检常显示免疫反应性IgM(85.3%),其荧光程度与双螺旋DNA抗体水平的升高直接相关(p<0.05)。在可能患有系统性红斑狼疮的检查患者中,47%的患者登记了狼疮带试验阳性,而72.2%的患者登记了IgM,这使他们更接近靠谱的系统性红斑狼疮患者组。然而,33.3%最可能的系统性红斑狼疮患者存在孤立的单一免疫反应物沉积,而靠谱系统性红斑狼疮的免疫反应(IgM + IgG)和(IgM + IgG + C3)的相关性分别为27.7例和5.5%。值得注意的是,C1q免疫反应在靠谱(38.2%)和可能的系统性红斑狼疮(39%)的皮肤活检中均检出。所获得的数据表明,具有特定免疫反应模式的狼疮带试验可作为诊断系统性红斑狼疮的一种附加试验。

HERALD of North-Western State Medical University named after I.I. Mechnikov. 2021;13(1):39-48
pages 39-48 views

Major predictive risk factors for cytokine storm in COVID-19 patients (Clinical trials)

Anisenkova A., Apalko S., Asaulenko Z., Bogdanov A., Vologzhanin D., Garbuzov E., Golota A., Kamilova T., Klitsenko O., Minina E., Mosenko S., Urazov S., Khobotnikov D., Sherbak S.

摘要

AIM: Searching for predictors of cytokine storm in patients with COVID-19 and creating a risk scale for this complication for practical implementation.

MATERIALS AND METHODS: The study included 458 patients with confirmed COVID-19 with signs of viral lung lesion according to computer tomography. The patients were divided into 2 groups: with a stable course of moderate severity (100 patients) and with progressive moderate, severe and extremely severe course (358 patients).

RESULTS: It has been established that the main risk factors for the development of cytokine storm in COVID-19 patients are interleukin-6 concentration >23 pg/ml, the dynamics of the index according to the NEWS scale ≥0, ferritin concentration >485 ng/ml, D-dimers >2,1, C-reactive protein >50 mg/l, the number of lymphocytes in the blood <0,72 ∙ 109/l, age ≥40 years. Cytokine storm incidence correlates with an increase in the number of risk factors. For practical use the scale is applied in 3 groups. In the patients of the first group (0-1 factor) almost no cytokine storm risk was detected, in the second group (2-3 factors) the probability of a storm was 55 % (increased by 35.5 times), in the third group (≥4 risk factors) reaches 96 % (increased by 718 times).

CONCLUSIONS: Diagnostic and monitoring criteria of cytokine storm in the patients with COVID-19 were established. The developed prognostic scale allows to identify patients at high risk of developing cytokine storm for early anti-inflammatory therapy.

HERALD of North-Western State Medical University named after I.I. Mechnikov. 2021;13(1):49-58
pages 49-58 views

细胞因子研究在COVID-19相关肺炎中的预后作用

Tkachenko O., Pervakova M., Lapin S., Mazing A., Kuznetsova D., Moshnikova A., Kholopova I., Blinova T., Surkova E., Kulikov A., Vorobyev E., Vorobyeva S., Stanevich O., Polushin Y., Shlyk I., Afanasyev A., Gavrilova E., Titova O., Volchkova E., Potapenko V., Khudonogova S., Mazurov V.

摘要

绪论2019新型冠状病毒(COVID-19)通常伴有细胞因子风暴综合征。尽管许多白细胞介素具有预测价值,但单一标记物的敏感性和特异性是有限的。

该研究的目的是建立一个客观和内容丰富性的细胞因子风暴量表,用于评估COVID-19相关肺炎患者发生关键病程的风险。

材料与方法。我们研究了226例COVID-19病例,其中36例(16%)因该病死亡。细胞因子IL-1b、IL-2、 IL-6、IL-8、IL-10、IL-18,á肿瘤坏死因子,á-干扰素,ã-干扰素采用VektorBest(俄罗斯)生产的商业试剂盒进行酶免疫分析。

结果。因为IL-6、IL-10、IL-18和降钙素原水平与疾病的严重程度和死亡相关,这些分数被整合成一个12分的量表,称为细胞因子风暴量表。得分超过6分的患者有疾病不良结局的高风险。ROC分析显示,细胞因子风暴量表的曲线下面积均大于四种标志物的曲线下面积[AUC 0.90 (95% CI 0.8455–0.9592),p<0.001]。

结论。因此,细胞因子风暴规模与COVID-19病程不良预后风险的信息含量相当高。

HERALD of North-Western State Medical University named after I.I. Mechnikov. 2021;13(1):59-69
pages 59-69 views

糜烂性反流性食管炎患者饮食行为的矫正

Tikhonov S., Simanenkov V., Bakulina N., Lishchuk N., Topalova Y.

摘要

目的是比较在糜烂性食管炎、超重和肥胖患者中,使用H+/K+-ATP酶抑制剂治疗1个月的有效性和6个月的饮食行为的纠正与最初的1个月和5个月的维持治疗使用H+/K+-ATP酶抑制剂。

材料与方法。随机临床试验包括29例糜烂性食管炎A级患者(平均年龄为54.8±13.5岁)。13例(45%)患者检测到超重,16例(55%)—肥胖,26例(90%)—腹部肥胖。患者被分为两组:对照组包括15例患者接受了4周奥美拉唑,剂量为20mg,每日2次,20周奥美拉唑,剂量为20mg,每日1次;干预组包括14名患者接受了4周的奥美拉唑,剂量为20mg,每天一次,并参加了24周的饮食行为矫正计划。在评估焦虑、抑郁水平、生活质量、糜烂性食管炎愈合情况、食管24小阻抗PH值监测时,比较治疗效果。

结果。4周治疗结束时,对照组的烧心(1.8±0.08比2.4±0.6分)、烧心强度(1.13±0.51比1.78±0.89分) 的频率较低,糜烂性食管炎的愈合更为频繁[13例(86%)比5例(35%)];以百分数表示,食管中轻度酸性(2.5±1.6比0.8±0.4%)和轻度碱性(0.44±0.3比0.15±0.2%)较多,碱性胃食管反流(9.1±9.8比2.8±3.9)较多。治疗6个月时,对照组的反流频率(3.46±0.5比2.28±0.7分)和反流强度(1.6±0.5比1.07±0.26分) 高于对照组;食道轻度酸性(2.32±1.86比0.89±0.57%)和轻度碱性时间(0.54±0.72比0.22±0.28%)越长,SF-36问卷GH和RE量表的生活质量越低。

结论。研究表明,在糜烂性食管炎和超重和肥胖患者中,纠正饮食行为比使用H+/K+-ATP酶抑制剂治疗更具优势。体重减轻对烧心和糜烂性食管炎的作用与H+/K+-ATP酶抑制剂治疗相似,对反流的作用更显著,并改善上消化道的运动性。

HERALD of North-Western State Medical University named after I.I. Mechnikov. 2021;13(1):71-84
pages 71-84 views

Chronic gastritis and precancerous diseases of the stomach: Is there a chance of a correct diagnosis?

Tryapitsyn A., Malkov V., Gasanov E., Belyakov I.

摘要

AIM: The purpose of the study is to investigate the occurrence of the main forms of chronic gastritis, metaplastic and dysplastic changes in the gastric mucosa, the degree of their severity, and to assess their potential risk for the development of gastric cancer.

MATERIALS AND METHODS: The study involved 2982 patients who underwent esophagogastroduodenoscopy with a standard biopsy of the gastric mucosa for morphological assessment and bacterioscopy. If autoimmune gastritis was suspected, an additional serological diagnosis was performed. When detecting intestinal metaplasia of the gastric mucosa as well as neoplastic changes according to the histological report, the description of this report was analyzed in order to identify possible equivalents in the macroscopic description of the mucous membrane.

RESULTS: Out of 2982 histological studies of gastric mucosa biopsies, 1273 cases (42.7%) were found to contain H. pylori contamination. In 726 cases (24.3%), intestinal metaplasia. 66 biopsies (2.21%) showed the presence of low-grade intraepithelial neoplasia of the mucosa, 2 biopsies showed indeterminate neoplasia and 4 biopsies showed high-grade neoplasia. In 3 out of the total number of the samples, intravascular gastric adenocarcinoma was detected. In 168 cases (5.6%), gastritis was detected with predominant inflammation of the fundal region characteristic of autoimmune gastritis. In 286 biopsies (10.6%), inflammatory and/or atrophic changes and/or metaplastic changes were preserved, which, as a rule, did not have high activity and pronounced inflammation. In the remaining 1279 cases (42.9%), there was no significant inflammation or atrophic changes. The analysis of endoscopic findings showed that the detectability of intestinal metaplasia of the gastric mucosa without a biopsy study was 13.3%.

DISCUSSION OF THE RESULTS: According to the results of the conducted research and analysis, it can be stated that at present, the correct diagnosis of chronic gastritis with the establishment of the etiological factor, prognosis and risks of stomach cancer development is practically not feasible within the modern health care system. This not only deprives a doctor of the opportunity to make a correct diagnosis and prescribe adequate treatment to a patient, but also makes almost all cascades of carcinogenesis, including early cancer, “invisible”.

HERALD of North-Western State Medical University named after I.I. Mechnikov. 2021;13(1):85-102
pages 85-102 views

The results of using endovascular methods for stopping ulcerative gastroduodenal bleeding

Sinenchenko G., Verbitskiy V., Demko A., Sekeyev A., Alentyev S., Kiselev M., Parfenov A., Alimov P.

摘要

This article presents the results of treatment of patients with ulcerative gastroduodenal bleeding who were treated in the 2nd clinic (surgery for the improvement of doctors) Military Medical Academy at the I.I. Dzhanelidze Research Institute of Emergency Medicine. A retrospective analysis was conducted of the frequency of rebleeding, surgical activity and mortality in groups with the use of transcatheter arterial embolization with and without it. The criteria for inclusion in the study were: the presence of ulcerative gastroduodenal bleeding, confirmed by laboratory and instrumental methods of examination, severe general somatic condition of patients. The comparison was carried out in the main and control groups. The main group consisted of 20 patients who underwent endovascular hemostasis. The control group included 46 patients without the use of X-ray surgical methods. The average age of patients in the main and control groups was 65.5 ± 3.7 and 60.7 ± 3.9 years. In both groups, most patients were admitted later than 24 hours after the onset of the disease and with severe blood loss. The severity of the somatic state of the intervention was assessed according to the APACHE II multiple organ failure assessment scale, according to which, patients in the main group were somatically more severe than in the control group. In the groups, bleeding from stomach ulcers prevailed (up to 75%). Most often, endovascular hemostasis is performed at a high risk of recurrent bleeding, and adhesive compositions and spirals were used as an embolizing agent. Angiography revealed direct or indirect signs of bleeding (extravasation, hypervascularization, aneurysmal dilatation) in 12 cases, and preventive embolization was performed in 8 cases. In 70% of cases, the source of bleeding was the left gastric artery. In the control group, recurrent bleeding and surgical activity accounted for 26%. In the main group, 20% and 15%, respectively. In the main group, recurrent bleeding occurred in 4 cases, 1 patient underwent repeated endoscopic hemostasis, 3 patients underwent open surgical interventions. All 4 patients had a fatal outcome, against the background of massive blood loss and aggravated somatic pathology. The overall mortality rate in the control group was 44%, in the main group 35%. Transcatheter arterial embolization did not significantly improve the results of treatment of ulcerative gastroduodenal bleeding due to the severity of the general somatic condition of the patients included in the study.

HERALD of North-Western State Medical University named after I.I. Mechnikov. 2021;13(1):103-108
pages 103-108 views

Parameters of intracardiac hemodynamics in iron deficiency in patients with chronic heart failure

Smirnova M., Chizhov P., Baranov A., Ivanova Y.

摘要

BACKGROUND: Iron deficiency is a common comorbidity in many patients with chronic heart failure.

AIM: To study the parameters of intracardiac hemodynamics in the patients with chronic heart failure in the presence of iron deficiency.

MATERIALS AND METHODS: We examined 179 patients (36 men and 143 women, mean age 71.6 ± 7.9 years) with heart failure of functional class 2-4 (NYHA). All the patients underwent a clinical examination, a 6-minute walk test, a general blood test; the level of NT-proBNP, iron, transferrin, and ferritin in blood serum were studied; the percentage of transferrin saturation with iron was calculated. The presence of iron deficiency was assessed based on a decrease in the level of serum ferritin less than 100 μg/L or ferritin ranging from 100 to 299 μg/L and saturation of transferrin with iron less than 20%. All the patients underwent echocardiography in one-dimensional, two-dimensional and Doppler modes (pulse-wave, constant-wave and tissue) in standard positions according to the generally accepted technique.

RESULTS: It was found that in the patients with chronic heart failure and iron deficiency compared with the patients without iron deficiency; the end systolic volume of the left ventricle, the size of the right ventricle and the systolic pressure in the pulmonary artery were significantly higher, and the speed of movement of the fibrous ring of the mitral and tricuspid valves and the working capacity were lower. Significant correlations were established between the concentration of iron and ferritin and the parameters of intracardiac hemodynamics.

CONCLUSIONS: Iron deficiency in the patients with chronic heart failure without anemia contributes to an early initial decrease in cardiac contractility with an intact ejection fraction.

HERALD of North-Western State Medical University named after I.I. Mechnikov. 2021;13(1):109-115
pages 109-115 views


##common.cookie##